TetraLogic Pharmaceuticals Co. (OTCMKTS:TLOG – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. TetraLogic Pharmaceuticals shares last traded at $0.00, with a volume of 0 shares trading hands.
TetraLogic Pharmaceuticals Stock Down 100.0%
TetraLogic Pharmaceuticals Company Profile
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells.
Further Reading
- Five stocks we like better than TetraLogic Pharmaceuticals
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Receive News & Ratings for TetraLogic Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TetraLogic Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
